<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Some new 1,3-disubstituted-2,3-dihydro-2-iminobenzimidazoles were synthesized using 1-(un)substituted-2-aminobenzimidazoles as precursors in order to determine their cytotoxicity </plain></SENT>
<SENT sid="1" pm="."><plain>The structures of the compounds were confirmed by IR, (1)H NMR, (13)C NMR and elemental analysis </plain></SENT>
<SENT sid="2" pm="."><plain>Compounds 4, 7-11 and 13-14 were evaluated for their cytotoxical effect on two <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell lines: human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell line HT-29, <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cells <z:chebi fb="14" ids="32506">MDA</z:chebi>-MB-231 and as well as <z:mpath ids='MPATH_458'>normal</z:mpath> spleen cells </plain></SENT>
<SENT sid="3" pm="."><plain>The distinctly marked antiproliferative activity of 1,3-bis(3-phenylpropyl-1)-1,3-dihydro-2H-<z:chebi fb="0" ids="36622">benzimidazol</z:chebi>-2-<z:chebi fb="0" ids="24783">imine</z:chebi> hydro <z:chebi fb="25" ids="15858">bromide</z:chebi> 7, N-(aminopropyl)-2-(3-{2-[(aminopropyl)-amino]-2-oxoethyl}-2-<z:chebi fb="0" ids="29342">imino</z:chebi>-2,3-dihydro-1H-<z:chebi fb="0" ids="36622">benzimidazol</z:chebi>-1-yl)<z:chebi fb="0" ids="27856">acetamide</z:chebi> 9 and 1,3-bis[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-2,3-dihydro-2H-<z:chebi fb="0" ids="36622">benzimidazol</z:chebi>-2-<z:chebi fb="0" ids="24783">imine</z:chebi> 11 against human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell line HT-29 was ascertained and the calculated IC(50) were 9.26, 0.56 and 0.013 nM respectively </plain></SENT>
<SENT sid="4" pm="."><plain>Compounds 4, 9, 10 and 13 exhibited relative high cytotoxic activity against <z:chebi fb="14" ids="32506">MDA</z:chebi>-MB-231 cells </plain></SENT>
<SENT sid="5" pm="."><plain>The calculated IC(50) values were in the range 0.123-1.65 nM </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> tested compounds excluding compound 1,3-bis[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-2,3-dihydro-2H-<z:chebi fb="0" ids="36622">benzimidazol</z:chebi>-2-<z:chebi fb="0" ids="24783">imine</z:chebi> (11) revealed proliferative activities to <z:mpath ids='MPATH_458'>normal</z:mpath> spleen cells </plain></SENT>
<SENT sid="7" pm="."><plain>The computed EC(50) values varied from 0.05 to 16.91 nM </plain></SENT>
</text></document>